Header Logo

Connection

Michael Bronze to Humans

Back to Details
This is a "connection" page, showing publications Michael Bronze has written about Humans.
Michael Bronze
Connection Strength
1.033
Humans
  1. On the Subject of Urinary Tract Infections in the Elderly. Am J Med Sci. 2020 09; 360(3):209-210.
    View in: PubMed
    Score: 0.040
  2. Journey of a strut: from filter to missile. Am J Med Sci. 2015 Jan; 349(1):92-3.
    View in: PubMed
    Score: 0.027
  3. Histoplasma infection of aortofemoral bypass graft. Am J Med Sci. 2014 May; 347(5):421-4.
    View in: PubMed
    Score: 0.026
  4. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol. J Virol Methods. 2013 Dec; 194(1-2):300-7.
    View in: PubMed
    Score: 0.025
  5. Risk of nocardial infections with anti-tumor necrosis factor therapy. Am J Med Sci. 2013 Aug; 346(2):166-8.
    View in: PubMed
    Score: 0.025
  6. Primary retroperitoneal abscess caused by Candida glabrata. Am J Med Sci. 2012 Oct; 344(4):332-4.
    View in: PubMed
    Score: 0.024
  7. Viral infections in patients with inflammatory bowel disease on immunosuppressants. Am J Med Sci. 2012 Mar; 343(3):227-32.
    View in: PubMed
    Score: 0.023
  8. Refractory hypoxia in an HIV-infected patient--a diagnostic challenge. Am J Emerg Med. 2012 Sep; 30(7):1322.e5-6.
    View in: PubMed
    Score: 0.022
  9. Internal medicine residency redesign. Ann Intern Med. 2011 Mar 15; 154(6):442-3.
    View in: PubMed
    Score: 0.021
  10. Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections. Am J Med Sci. 2010 Sep; 340(3):218-25.
    View in: PubMed
    Score: 0.020
  11. Emerging pathogens and knowledge in infectious diseases. Am J Med Sci. 2010 Sep; 340(3):177-80.
    View in: PubMed
    Score: 0.020
  12. Infection caused by Rahnella aquatilis. Am J Med Sci. 2010 Jun; 339(6):577-9.
    View in: PubMed
    Score: 0.020
  13. Robert Koch and the 'golden age' of bacteriology. Int J Infect Dis. 2010 Sep; 14(9):e744-51.
    View in: PubMed
    Score: 0.020
  14. Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis. Am J Med Sci. 2010 Feb; 339(2):169-73.
    View in: PubMed
    Score: 0.020
  15. Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. Cleve Clin J Med. 2008 Jul; 75(7):521-30.
    View in: PubMed
    Score: 0.018
  16. Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasion. FEMS Immunol Med Microbiol. 2008 Jul; 53(2):151-65.
    View in: PubMed
    Score: 0.017
  17. A confusing case of confusion. Acute porphyrias. J Okla State Med Assoc. 2008 Apr; 101(4):85-6, 89-90.
    View in: PubMed
    Score: 0.017
  18. Gatifloxacin-associated hypoglycemia. J Okla State Med Assoc. 2007 Nov; 100(11):425-8.
    View in: PubMed
    Score: 0.017
  19. Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide. J Okla State Med Assoc. 2007 Jul; 100(7):267-72.
    View in: PubMed
    Score: 0.016
  20. Part VII. Macrolides, azalides, ketolides, lincosamides, and streptogramins. J Okla State Med Assoc. 2007 Mar; 100(3):75-81.
    View in: PubMed
    Score: 0.016
  21. Antimicrobial symposium. Part 1. Principles of antimicrobial therapy. J Okla State Med Assoc. 2006 Sep; 99(9):474-9.
    View in: PubMed
    Score: 0.015
  22. Clinical problem-solving. Still consider the source. N Engl J Med. 2005 Oct 06; 353(14):1503-7.
    View in: PubMed
    Score: 0.014
  23. Overview and management of obesity in adults. J Okla State Med Assoc. 2004 Oct; 97(10):422-6.
    View in: PubMed
    Score: 0.014
  24. From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. Int J Mol Sci. 2024 Jun 12; 25(12).
    View in: PubMed
    Score: 0.013
  25. Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism. Curr Opin Investig Drugs. 2004 Feb; 5(2):135-40.
    View in: PubMed
    Score: 0.013
  26. Terrorism symposium update and conclusion. J Okla State Med Assoc. 2003 Dec; 96(12):575-8.
    View in: PubMed
    Score: 0.013
  27. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents. Drug Discov Today. 2003 Oct 01; 8(19):881-8.
    View in: PubMed
    Score: 0.013
  28. Preventive and therapeutic approaches to viral agents of bioterrorism. Drug Discov Today. 2003 Aug 15; 8(16):740-5.
    View in: PubMed
    Score: 0.012
  29. Therapeutic options for diseases due to potential viral agents of bioterrorism. Curr Opin Investig Drugs. 2003 Feb; 4(2):172-8.
    View in: PubMed
    Score: 0.012
  30. The potential role of viral pathogens as agents of bioterrorism. J Okla State Med Assoc. 2003 Jan; 96(1):29-33.
    View in: PubMed
    Score: 0.012
  31. Symposium introduction: clinical aspects of terrorism. J Okla State Med Assoc. 2002 Sep; 95(9):583-6.
    View in: PubMed
    Score: 0.012
  32. Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer. Gastroenterology. 2022 11; 163(5):1281-1293.e1.
    View in: PubMed
    Score: 0.012
  33. Terrorism from a public health perspective. Am J Med Sci. 2002 Jun; 323(6):291-8.
    View in: PubMed
    Score: 0.011
  34. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci. 2002 Jun; 323(6):299-315.
    View in: PubMed
    Score: 0.011
  35. Viral agents as biological weapons and agents of bioterrorism. Am J Med Sci. 2002 Jun; 323(6):316-25.
    View in: PubMed
    Score: 0.011
  36. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci. 2002 Jun; 323(6):326-40.
    View in: PubMed
    Score: 0.011
  37. Chagas disease in Oklahoma. Am J Med Sci. 2022 Nov; 364(5):521-528.
    View in: PubMed
    Score: 0.011
  38. Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-ß Signaling Axis in Pancreatic Cancer. Gastroenterology. 2022 06; 162(7):2004-2017.e2.
    View in: PubMed
    Score: 0.011
  39. Interplay of Tumor Microenvironment Factors and Cancer Stem Cell Enrichment in Pancreatic Ductal Adenocarcinoma. Gastroenterology. 2021 12; 161(6):1800-1802.
    View in: PubMed
    Score: 0.011
  40. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer. Gastroenterology. 2021 04; 160(5):1771-1783.e1.
    View in: PubMed
    Score: 0.010
  41. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clin Infect Dis. 2000 Dec; 31(6):1488-92.
    View in: PubMed
    Score: 0.010
  42. Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019. Clin Gastroenterol Hepatol. 2021 Jul; 19(7):1355-1365.e4.
    View in: PubMed
    Score: 0.010
  43. Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical ß-catenin-dependent mechanism. Sci Rep. 2020 06 29; 10(1):10578.
    View in: PubMed
    Score: 0.010
  44. DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization. Mol Cancer Ther. 2020 07; 19(7):1539-1549.
    View in: PubMed
    Score: 0.010
  45. Sternal osteomyelitis caused by mycobacterium tuberculosis: case report and review of the literature. Am J Med Sci. 2000 Apr; 319(4):250-4.
    View in: PubMed
    Score: 0.010
  46. Infectious aortitis: an uncommon manifestation of infection with Streptococcus pneumoniae. Am J Med. 1999 Dec; 107(6):627-30.
    View in: PubMed
    Score: 0.010
  47. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin a3ß1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. Gastroenterology. 2020 02; 158(3):679-692.e1.
    View in: PubMed
    Score: 0.010
  48. Isoniazid drug and food interactions. Am J Med Sci. 1999 May; 317(5):304-11.
    View in: PubMed
    Score: 0.009
  49. Urinary tract aspergillosis in a renal transplant recipient. Clin Infect Dis. 1998 Nov; 27(5):1336.
    View in: PubMed
    Score: 0.009
  50. ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells. Gastroenterology. 2019 02; 156(3):722-734.e6.
    View in: PubMed
    Score: 0.009
  51. False-positive enzyme immunoassay for human immunodeficiency virus due to acute cytomegalovirus infection. Clin Infect Dis. 1998 Jul; 27(1):221-2.
    View in: PubMed
    Score: 0.009
  52. Citrobacter freundii empyema in a patient with occult pulmonary histoplasmosis. Am J Med Sci. 1998 May; 315(5):314-6.
    View in: PubMed
    Score: 0.009
  53. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. Int J Cancer. 2018 09 01; 143(5):1162-1175.
    View in: PubMed
    Score: 0.009
  54. ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism. Clin Cancer Res. 2018 07 01; 24(13):3186-3196.
    View in: PubMed
    Score: 0.009
  55. Immunoblastic lymphadenopathy presenting as an acute abdomen and mixed bacteremia with Eikenella corrodens and group C streptococci. Am J Gastroenterol. 1998 Apr; 93(4):652-3.
    View in: PubMed
    Score: 0.009
  56. Group G streptococcal arthritis: case report and review of the literature. Am J Med Sci. 1997 Apr; 313(4):239-43.
    View in: PubMed
    Score: 0.008
  57. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells. Mol Cancer. 2017 02 01; 16(1):30.
    View in: PubMed
    Score: 0.008
  58. Infective endocarditis caused by Streptococcus pneumoniae with high-level resistance to penicillin and cephalosporin. Clin Infect Dis. 1996 Nov; 23(5):1176-7.
    View in: PubMed
    Score: 0.008
  59. Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa. J Infect Dis. 2016 Dec 15; 214(12):1826-1830.
    View in: PubMed
    Score: 0.008
  60. HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. J Antimicrob Chemother. 2017 01; 72(1):210-219.
    View in: PubMed
    Score: 0.008
  61. Case report: Candida zeylanoides infective endocarditis complicating infection with the human immunodeficiency virus. Am J Med Sci. 1996 Sep; 312(3):138-9.
    View in: PubMed
    Score: 0.008
  62. Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase. Cancer Res. 2016 07 15; 76(14):4090-9.
    View in: PubMed
    Score: 0.008
  63. (Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression. Cancer Res. 2016 08 15; 76(16):4887-96.
    View in: PubMed
    Score: 0.008
  64. The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am J Med Sci. 1996 Jan; 311(1):41-54.
    View in: PubMed
    Score: 0.007
  65. Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal. Oncotarget. 2015 Oct 13; 6(31):30876-86.
    View in: PubMed
    Score: 0.007
  66. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Oncotarget. 2015 Aug 21; 6(24):20327-44.
    View in: PubMed
    Score: 0.007
  67. Lower frequency of NPM1 and FLT3-ITD mutations in a South African adult de novo AML cohort. Int J Lab Hematol. 2014 Dec; 36(6):656-64.
    View in: PubMed
    Score: 0.007
  68. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism. PLoS One. 2013; 8(11):e80304.
    View in: PubMed
    Score: 0.006
  69. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol. 1993 Sep 01; 151(5):2820-8.
    View in: PubMed
    Score: 0.006
  70. Warfarin management using point-of-care testing in a university-based internal medicine resident clinic. Am J Med Sci. 2012 Oct; 344(4):289-93.
    View in: PubMed
    Score: 0.006
  71. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J Immunol. 1992 Feb 01; 148(3):888-93.
    View in: PubMed
    Score: 0.006
  72. Prophylactic vaccine approach for colon and pancreatic cancers: present and future. Curr Med Chem. 2012; 19(22):3664-78.
    View in: PubMed
    Score: 0.006
  73. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts. J Virol. 2011 Dec; 85(23):12292-303.
    View in: PubMed
    Score: 0.005
  74. Competency-based education and training in internal medicine. Ann Intern Med. 2010 Dec 07; 153(11):751-6.
    View in: PubMed
    Score: 0.005
  75. Infectious agents of food- and water-borne illnesses. Am J Med Sci. 2010 Sep; 340(3):238-46.
    View in: PubMed
    Score: 0.005
  76. Osteoporosis in inflammatory bowel disease. Am J Med. 2009 Jul; 122(7):599-604.
    View in: PubMed
    Score: 0.005
  77. Mycobacterium bovis infection of an axillary-femoral bypass graft after intravesical bacille Calmette-Guérin immunotherapy for bladder cancer. Am J Med Sci. 2009 Jan; 337(1):63-4.
    View in: PubMed
    Score: 0.005
  78. Part XV. Antiretroviral therapy for human immunodeficiency virus infection. J Okla State Med Assoc. 2007 Nov; 100(11):417-24.
    View in: PubMed
    Score: 0.004
  79. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. J Okla State Med Assoc. 2007 Oct; 100(10):388-95.
    View in: PubMed
    Score: 0.004
  80. Part XIII. Systemic antifungal therapy. J Okla State Med Assoc. 2007 Sep; 100(9):344-51.
    View in: PubMed
    Score: 0.004
  81. Part X. Tetracycline and glycylcycline antimicrobials. J Okla State Med Assoc. 2007 Jun; 100(6):241-7.
    View in: PubMed
    Score: 0.004
  82. Part IX. Quinolone antimicrobials. J Okla State Med Assoc. 2007 May; 100(5):149-56.
    View in: PubMed
    Score: 0.004
  83. Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides. J Okla State Med Assoc. 2007 Apr; 100(4):105-11.
    View in: PubMed
    Score: 0.004
  84. Antimicrobial symposium. Part VI. Aminoglycosides and polymyxins. J Okla State Med Assoc. 2007 Feb; 100(2):60-4.
    View in: PubMed
    Score: 0.004
  85. Protective and heart-cross-reactive epitopes of type 19 streptococcal M protein. Trans Assoc Am Physicians. 1987; 100:80-4.
    View in: PubMed
    Score: 0.004
  86. Part V. Other beta-lactam antimicrobials. J Okla State Med Assoc. 2007 Jan; 100(1):23-5.
    View in: PubMed
    Score: 0.004
  87. Antimicrobial symposium. Part IV. Cephalosporins. J Okla State Med Assoc. 2006 Dec; 99(12):579-83.
    View in: PubMed
    Score: 0.004
  88. Part III. Penicillins. J Okla State Med Assoc. 2006 Nov; 99(11):551-6.
    View in: PubMed
    Score: 0.004
  89. Part II. Introduction to the beta-lactam antibiotics. J Okla State Med Assoc. 2006 Oct; 99(10):516-20.
    View in: PubMed
    Score: 0.004
  90. Clinical problem-solving. Step by step. N Engl J Med. 2003 Dec 04; 349(23):2253-7.
    View in: PubMed
    Score: 0.003
  91. Other bacterial diseases as a potential consequence of bioterrorism: Q fever, brucellosis, glanders, and melioidosis. J Okla State Med Assoc. 2003 May; 96(5):214-7.
    View in: PubMed
    Score: 0.003
  92. Influenza virus: natural disease and bioterrorism threat. J Okla State Med Assoc. 2003 Jan; 96(1):27-8.
    View in: PubMed
    Score: 0.003
  93. Effects of methylprednisolone on intracellular bacterial growth. Clin Diagn Lab Immunol. 2001 Nov; 8(6):1156-63.
    View in: PubMed
    Score: 0.003
  94. Enhanced extracellular growth of Staphylococcus aureus in the presence of selected linear peptide fragments of human interleukin (IL)-1beta and IL-1 receptor antagonist. J Infect Dis. 2001 Jan 01; 183(1):65-69.
    View in: PubMed
    Score: 0.003
  95. Effects of cytokines and endotoxin on the intracellular growth of bacteria. Infect Immun. 1999 Jun; 67(6):2834-40.
    View in: PubMed
    Score: 0.002
  96. Analysis of the role of M24 protein in group A streptococcal adhesion and colonization by use of omega-interposon mutagenesis. Infect Immun. 1994 Nov; 62(11):4868-73.
    View in: PubMed
    Score: 0.002
  97. Lipoteichoic acid and M protein: dual adhesins of group A streptococci. Microb Pathog. 1992 Mar; 12(3):199-208.
    View in: PubMed
    Score: 0.001
  98. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium. J Immunol. 1991 May 01; 146(9):3132-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.